Your browser doesn't support javascript.
loading
Progress in Molecular Mechanisms and Cell Transplantation Therapy of Parkinson's Disease / 中国药学杂志
Chinese Pharmaceutical Journal ; (24): 1487-1491, 2020.
Article in Zh | WPRIM | ID: wpr-857580
Responsible library: WPRO
ABSTRACT
Neuron is the basic structure and functional unit of nervous system. Once the neurons are damaged or lost, the balance of neuroregulation will be destroyed and a series of nervous system diseases will be induced. Parkinson's disease (PD) is a kind of chronic neurodegenerative disease caused by selective loss of many dopaminergic neurons in the dense region of the substantia nigra in the ventral midbrain. At present, conventional drugs and adjuvant therapies can only relieve clinical symptoms to a certain extent, but cannot fundamentally delay the progress of the disease. With the rapid development of stem cells and reprogramming technologies around the world, cell transplantation to deal with neurodegenerative diseases including Parkinson's disease has become a new and potential therapy. This paper mainly summarizes the molecular mechanisms of Parkinson's disease, the preparation of autogenous dopaminergic neurons and the research progresses of dopaminergic neurons transplantation in the treatment of Parkinson's disease.
Key words
Full text: 1 Database: WPRIM Language: Zh Journal: Chinese Pharmaceutical Journal Year: 2020 Document type: Article
Full text: 1 Database: WPRIM Language: Zh Journal: Chinese Pharmaceutical Journal Year: 2020 Document type: Article